Novel Drug Lowers Stubbornly High BP in Phase 3 Trial ...Middle East

News by : (Medscape) -
Lorundrostat, an aldosterone synthase inhibitor, effectively treated uncontrolled hypertension in Launch-HTN, researchers reported in JAMA. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel Drug Lowers Stubbornly High BP in Phase 3 Trial )

Also on site :

Most Viewed News
جديد الاخبار